Katherine A. Cheng

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

Medicine, Genetics, Oncology +10

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata et al. · Cancer Cell · 2012 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

Neil Johnson, Yuchen Li, Zandra E. Walton et al. · Nature Medicine · 2011 · 306 citations

Medicine, Cancer Biology, Oncology +15

A family of intermediate filament-like proteins is sequentially assembled into the cytoskeleton of Toxoplasma gondii

Brooke R. Anderson‐White, F. Douglas Ivey, Katherine A. Cheng et al. · Cellular Microbiology · 2010 · 211 citations · Full text

Life Sciences, Cell Biology, Microbiology +16

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer

Takeshi Shimamura, Zhao Chen, Margaret Soucheray et al. · Clinical Cancer Research · 2013 · 204 citations · Full text

Medicine, Molecular Biology, Oncology +17